Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical and Experimental Immunology|April 12, 2000
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA)C Ribbens, V Bonnet, M J Kaiser, et al.
Immunology Letters|August 1, 1987
In vitro effects of thymopentin on the gamma-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritisM G Malaise, M Bastings, A M Reuter, et al.
Rheumatology (Oxford, England)|January 4, 2001
Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or notC Ribbens, B Andre, O Kaye, et al.
Annals of the Rheumatic Diseases|January 18, 2002
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatmentC Ribbens, M Martin y Porras, N Franchimont, et al.
Lancet (London, England)|April 13, 1985
Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. A double-blind placebo-controlled randomised studyM G Malaise, C Hauwaert, P Franchimont, et al.
Revue Medicale De Liege|January 21, 2010
[Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest]D De Seny, C Ribbens, G Cobraiville, et al.
Osteoarthritis and Cartilage|August 31, 2015
Restriction of spontaneous and prednisolone-induced leptin production to dedifferentiated state in human hip OA chondrocytes: role of Smad1 and β-catenin activationE Charlier, O Malaise, M Zeddou, et al.
Annals of the Rheumatic Diseases|December 3, 2003
Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II studyL B A van de Putte, R Rau, F C Breedveld, et al.
Pageof 5